Garveish Herbaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.00 M
as on 22-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 22-12-2024
- Revenue 42.74%
(FY 2021)
- Profit 60.97%
(FY 2021)
- Ebitda 383.13%
(FY 2021)
- Net Worth 591.63%
(FY 2021)
- Total Assets 88.96%
(FY 2021)
About Garveish Herbaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.50 M.
Vijay Kumar, Kedar Dashore, and Ajay Dashore serve as directors at the Company.
- CIN/LLPIN
U74999MP2017PTC043381
- Company No.
043381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Burhanpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Garveish Herbaceuticals Private Limited offer?
Garveish Herbaceuticals Private Limited offers a wide range of products and services, including Personal Care, Oral Care, Ayurveda Products, Natural Hair & Skin Care.
Who are the key members and board of directors at Garveish Herbaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Kumar  | Director | 23-May-2017 | Current |
| Kedar Dashore | Director | 23-May-2017 | Current |
| Ajay Dashore | Director | 23-May-2017 | Current |
Financial Performance of Garveish Herbaceuticals.
Garveish Herbaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 42.74% increase. The company also saw a substantial improvement in profitability, with a 60.97% increase in profit. The company's net worth Soared by an impressive increase of 591.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Garveish Herbaceuticals?
In 2021, Garveish Herbaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Dec 2020 | ₹4.50 M | Open |
How Many Employees Work at Garveish Herbaceuticals?
Unlock and access historical data on people associated with Garveish Herbaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Garveish Herbaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garveish Herbaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
